Thyro-Tab 0 — Class II drug recall D-1392-2012
Terminated recall by Lloyd Inc, reported 2012-07-04, distributed nationwide. Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.
| Recall number | D-1392-2012 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lloyd Inc, Shenandoah, IA, United States |
| Recall initiated | 2012-02-03 |
| Classified | 2012-06-22 |
| Reported by FDA | 2012-07-04 |
| Terminated | 2013-07-30 |
| Distributed | Nationwide (US) |
| Quantity | 1,924,297 bulk |
| Reason classes | potency |
| Lot numbers | HB06311 |
Product
Thyro-Tab 0.050mg., packaged in bulk drums for repackaging. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Reason for recall
Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1392-2012. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.